The SA Node is a small cluster of specialized heart cells that initiates the normal heartbeat. It is part of cardiac anatomy and physiology, specifically the heart’s electrical conduction system. Clinically, it is discussed in rhythm diagnosis, bradycardia and tachycardia evaluation, and pacemaker decision-making.
The Cardiac Conduction System is the heart’s built-in electrical network that initiates and coordinates each heartbeat. It is a core topic in cardiac anatomy and physiology with direct relevance to arrhythmias and bradycardia. It is commonly assessed using the electrocardiogram (ECG/EKG), telemetry, and ambulatory rhythm monitors. It also guides clinical decisions in electrophysiology, device therapy (pacemakers/ICDs), and perioperative care.
Revascularization means restoring blood flow to tissue that is underperfused. In cardiology, it most often refers to reopening or bypassing narrowed coronary arteries. It is a therapeutic concept that can be delivered by catheter-based intervention or surgery. It is commonly discussed in acute coronary syndrome (ACS) and chronic coronary disease with ischemia.
Myocardial Hibernation is a state of chronically reduced heart muscle contraction caused by persistently reduced blood flow. It describes potentially reversible left ventricular (LV) dysfunction in the setting of coronary artery disease (CAD). It is a physiologic and pathophysiologic concept used in cardiology, cardiac imaging, and cardiothoracic decision-making. It is commonly discussed when evaluating ischemic cardiomyopathy and considering revascularization.
Myocardial Stunning describes a temporary reduction in heart muscle contraction after a brief period of ischemia (reduced blood flow) followed by reperfusion (restoration of flow). It is a physiologic and clinical concept used in cardiology, critical care, and perioperative cardiac care. It most often comes up after acute coronary syndromes, percutaneous coronary intervention (PCI), cardiac surgery, or resuscitation events. The key feature is reversibility: systolic dysfunction persists for hours to days despite restored perfusion and no ongoing ischemia.
Myocardial Ischemia is inadequate blood flow and oxygen delivery to the heart muscle (myocardium) relative to its metabolic demand. It is a pathophysiologic concept most commonly discussed in coronary artery disease (CAD) and acute coronary syndromes (ACS). It is used in clinical diagnosis, risk stratification, and treatment planning across emergency, inpatient, and outpatient cardiology. It is assessed using symptoms, electrocardiography (ECG), biomarkers, and cardiac imaging or invasive testing.
Cardiac Fibrosis is the abnormal buildup of fibrous connective tissue within the heart, most often in the myocardium (heart muscle). In plain terms, it is “scarring” or “stiffening” of heart tissue that can disrupt pumping and electrical conduction. It is a pathologic process discussed across cardiology, heart failure medicine, electrophysiology, and cardiac imaging. It is commonly referenced when interpreting echocardiography and cardiac magnetic resonance (CMR) findings, and when assessing prognosis.
Interventricular Septum Defect is a defect (opening) in the wall between the left and right ventricles. It is most commonly discussed in the domain of congenital heart disease, but it can also be acquired after myocardial infarction (heart attack). Clinically, it is evaluated as a cause of a cardiac murmur, abnormal intracardiac blood flow (shunt), and heart failure physiology. It is commonly identified and characterized using echocardiography and sometimes cardiac catheterization.
The Interatrial Septum is the wall of tissue that separates the right atrium from the left atrium. It is a core structure in cardiac anatomy and is closely tied to congenital heart disease and intracardiac blood flow patterns. Clinicians commonly assess it with echocardiography and cardiac imaging to evaluate shunts, embolic risk, and atrial structure. It is also a key landmark for procedures that require access to the left atrium.
Structural Heart Disease refers to abnormalities of the heart’s anatomy that affect how blood flows through the heart and great vessels. It is a clinical domain spanning diagnosis (imaging and hemodynamics) and treatment (medical therapy, catheter-based intervention, and surgery). The term is commonly used in cardiology, cardiothoracic surgery, echocardiography, and multidisciplinary “heart team” decision-making. It most often centers on cardiac valves, congenital defects, chambers, and adjacent structures such as the aorta.